Company intelligence / Profile preview

Pfanstiehl

Waukegan, Illinois, United Statespfanstiehl.com ↗

Ownership: Private
Employees: ~80
Development stage: Commercial

Overview

Pfanstiehl is a global leader in the manufacture of high-purity injectable-grade excipients and APIs under cGMP standards. Their products are critical components in many market-leading biopharmaceuticals and vaccines addressing life-threatening diseases. The company does not develop its own therapeutic pipeline but enables drug development through its excipients and custom synthesis services.

Modalities: Small moleculeBiologic excipients (e.g., carbohydrates, sugars for stabilization)
Industry: Chemicals & Materials

Partnerships

Pfanstiehl supplies leading global biopharmaceutical companies but specific partnerships are not disclosed publicly.Historical partnership with Abbott Laboratories on parenteral nutrition formulation noted

Beyond the preview

Go deeper on Pfanstiehl.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pfanstiehl.

Explore the full profile